Concord Medical Services Celebrates IPO, First Day of NYSE Trading
“We are pleased with the success of our initial public offering and the beginning of our partnership with the NYSE,” said Dr. Yang Jianyu, CEO and President of CMS. “We believe that through this IPO, CMS can connect the medical services industry in China with the international capital markets, and provide international investors the opportunity to participate in the growth of the Chinese healthcare sector.”
“Through its NYSE listing, Concord Medical has the opportunity to establish a strong footprint in the U.S. , access the world’s largest pool of investors, and grow its presence in the international capital markets,” said Michael Yang, Chief Representative and Head of China office, NYSE Euronext. “We look forward to strong and lasting partnerships with CMS and its shareholders.”
NYSE Euronext currently lists 79 companies from Greater China with a combined total global market capitalization of approximately $1.1 trillion (as of 12/11/09), including 18 companies from China on NYSE Amex.
Please click here for a photo of the company visiting the NYSE:
http://www.nyse.com/images/about/CMSPhoto.JPG
NYSE Euronext lists more issues than any other exchange
NYSE Euronext markets list 8,000 issues with a total combined market capitalization of $21.4 trillion (as of Nov. 30, 2009), more than any other exchange group in the world.
About Concord Medical Services Holdings Limited
CMS operates China 's largest network of radiotherapy and diagnostic imaging centers in terms of revenue and total number of centers in operation in 2008. Since the establishment, CMS has been committed to building an extensive network of radiotherapy and diagnostic imaging centers in China , employing state-of-the art medical technology to sustain lives and reduce suffering. Today, the Company operates a network of more than 80 centers spanning more than 35 cities and 20 provinces and administrative regions in China . Learn more at http://www.cmsholdings.com/.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
